Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring
STK11
or
KEAP1
mutation
OncoImmunology | January 15, 2021 | Volume: 10 | Issue: 1 | Pages: No page available
10.1080/2162402x.2020.1865670
| PMID 33537171